§
Luxuse
Patent Intelligence
Sign In
← Back to Patent Explorer
US5766618A Expired / Lapsed US ⏱️ 0.0 years remaining

Polymeric-hydroxyapatite bone composite

Assignee: Massachusetts Institute of Technology
•
Filing: 1997-03-05
•
Granted: 1998-06-16
•
Expires: 2017-03-05
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract A method for the fabrication of three-dimensional macroporous polymer matrices for use as bone graft or implant material was developed. The composites are formed from a mixture of biodegradable, biocompatible polymer and hydroxyapatite (HA), a particulate calcium phosphate ceramic. The method leaves irregular pores in the composite between 100 and 250 microns in size. In a preferred embodiment, implants are composed of a 50:50 poly(lactide-co-glycolide) (PLGA) polymer and reinforced by hydroxyapatite. Mechanical and histological analysis showed the matrix fabricated by this method to be structurally and mechanically similar to cancellous bone. Prior to degradation, pure polymer specimens exhibited an elastic modulus of 293 MPa and specimens which were 50% HA by weight exhibited a modulus of 1459 MPa. After six weeks of degradation under physiological conditions, the reinforcing effect of ceramic loading had diminished. Modulus of polymer matrices at all HA load levels had decreased sharply to approximately 10 MPa. Mean macro- and micropore diameters of the polymer specimens were 100 μm and 20 μm respectively and remained constant throughout degradation.

Inventors

  • 👤 Cato T. Laurencin
  • 👤 Jessica Devin
  • 👤 Muhammed Attawia

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-23 10:39
CPC Classifications
C; C08; C08L; C08L85/00; C08L85/02; A; A61; A61L; A61L27/00; A61L27/40; A61L27/44; A61L27/46; A61L2430/00; A61L2430/02

Claims Analysis

Total Claims: 14
Claim 1
Independent Claim 42 words
A porous composite comprising hydroxyapatite particles having a diameter in the range of between approximately 10 microns and 100 microns mixed with a biodegradable, biocompatible polymer wherein the pores have a diameter in the range of between approximately 100 and 250 microns.
Claim 2
Dependent Claim 42 words
A porous composite comprising hydroxyapatite particles having a diameter in the range of between approximately 10 microns and 100 microns mixed with a biodegradable, biocompatible polymer wherein the pores have a diameter in the range of between approximately 100 and 250 microns.
Claim 3
Dependent Claim 27 words
The composite of claim 1 wherein the biodegradable, biocompatible polymer is selected from the group consisting of polyanhydrides, polyhydroxy acids, polyorthoesters, polyphosphazenes, blends thereof, and copolymers thereof.
Claim 4
Dependent Claim 8 words
The composite of claim 1 further comprising osteoblasts.
Claim 5
Dependent Claim 33 words
The composite of claim 1 wherein the hydroxyapatite is selected from the group consisting of natural and synthetic hydroxyapatite, bone, cementum, dentin, enamel, tricalcium phosphate, calcium phosphate (CaPO 4 ), and combinations thereof.
Claim 6
Dependent Claim 26 words
The composite of claim 1 further comprising a biologically active material selected from the group consisting of antibiotics, chemotherapeutics, bone cell inducers and bone cell stimulators.
Claim 7
Dependent Claim 57 words
A process for treating a bone defect comprising implanting at the site of the defect a porous composite comprising hydroxyapatite particles having a diameter in the range of between approximately 10 microns and 100 microns mixed with a biodegradable, biocompatible polymer wherein the pores have a diameter in the range of between approximately 100 and 250 microns.
Claim 8
Dependent Claim 57 words
A process for treating a bone defect comprising implanting at the site of the defect a porous composite comprising hydroxyapatite particles having a diameter in the range of between approximately 10 microns and 100 microns mixed with a biodegradable, biocompatible polymer wherein the pores have a diameter in the range of between approximately 100 and 250 microns.
Claim 9
Dependent Claim 25 words
The process of claim 6 wherein the polymer is selected from the group consisting of polyanhydrides, polyhydroxy acids, polyorthoesters, polyphosphazenes, and blends and copolymers thereof.
Claim 10
Dependent Claim 15 words
The process of claim 6 further comprising seeding the composite with osteoblasts prior to implantation.
Claim 11
Dependent Claim 33 words
The process of claim 6 wherein the hydroxyapatite is selected from the group consisting of natural and synthetic hydroxyapatite, bone, cementum, dentin, enamel, tricalcium phosphate, calcium phosphate (CaPO 4 ), and combinations thereof.
Claim 12
Dependent Claim 32 words
The process of claim 6 further comprising administering at the site of implantation a biologically active material selected from the group consisting of antibiotics, chemotherapeutics, bone cell inducers and bone cell stimulators.
Claim 13
Dependent Claim 13 words
The composite of claim 1 wherein the hydroxyapatite comprises organic material and ions.
Claim 14
Dependent Claim 13 words
The process of claim 6 wherein the hydroxyapatite comprises organic material and ions.

References Cited (Backward Citations)

US5383931A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 2001-06-15 2001-12-15 2002-06-16 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 2005-06-15 2005-12-15 2006-06-16 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 2009-06-15 2009-12-15 2010-06-16 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag